✦ LIBER ✦

Initial results of a phase II trial of high dose radiation therapy, 5-fluorouracil, and cisplatin for patients with anal cancer (E4292): An eastern cooperative oncology group study

✍ Scribed by James A. Martenson; Stuart R. Lipsitz; Henry Wagner Jr.; Edward H. Kaplan; Larry A. Otteman; Lynn M. Schuchter; Edward G. Mansour; Mark S. Talamonti; Al Bowen Benson III

Publisher: Elsevier Science
Year: 1996
Tongue: English
Weight: 606 KB
Volume: 35
Category: Article
ISSN: 0360-3016
DOI: 10.1016/0360-3016(96)00146-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Results of combined modality therapy for

Results of combined modality therapy for patients with anal cancer (E7283). An eastern cooperative oncology group study

✍ James A. Martenson; Stuart R. Lipsitz; Myrto Lefkopoulou; Paul F. Engstrom; Yoge 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 505 KB

A randomized Phase II trial of echinomyc

A randomized Phase II trial of echinomycin, trimetrexate, and cisplatin plus etoposide in patients with metastatic nonsmall cell lung carcinoma : An Eastern Cooperative Oncology Group Study (E1587)

✍ Alex Y. Chang; KyungMann Kim; Hélène Boucher; Philip Bonomi; James A. Stewart; D 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB 👁 2 views

## Background: Patients with metastatic nonsmall cell lung carcinoma (nsclc) usually have a poor prognosis. a chemotherapy regimen containing cisplatin is commonly used for symptom palliation. echinomycin is a potent bifunctional intercalator of double-strand dna; trimetrexate is a new derivative o

A phase II study of 5-fluorouracil, leuc

A phase II study of 5-fluorouracil, leucovorin, and interferon-α in the treatment of patients with metastatic or recurrent gastric carcinoma : An Eastern Cooperative Oncology Group study (E5292)

✍ Gary R. Hudes; Stuart Lipsitz; Jean Grem; Mary Morrisey; Louis Weiner; John W. K 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB 👁 1 views

Chemotherapy has a limited impact on adenocarcinoma of the stomach. Although biochemical modulation of 5-fluorouracil (5-FU) by leucovorin (LV) and interferon-␣ (IFN-␣) has improved the outcomes of patients with metastatic colorectal carcinoma compared with 5-FU alone, this approach has not been ext